Paper Differential

Row	Disease	Sample Type	Official Symbol	Sign Of Difference	Experimental Design	Control	Case	P Value	Type Of Study	Organism	Variable Name	Variable Category	Case Count	Control Count	Technique
768	CEES Exposure	Bronchoalveolar Lavage (BAL)	Total protein	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat		Phenotype	3	6	BCA assay
769	CEES Exposure	Bronchoalveolar Lavage (BAL)	Total protein	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat		Phenotype	6	6	BCA assay
811	CEES Exposure	Bronchoalveolar Lavage (BAL)	IgM	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	3	6	Enzyme-linked immunosorbent assay (ELISA)
812	CEES Exposure	Bronchoalveolar Lavage (BAL)	IgM	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	6	6	Enzyme-linked immunosorbent assay (ELISA)
813	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAT	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	5	5	Enzyme-linked immunosorbent assay (ELISA)
814	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAT	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	5	5	Enzyme-linked immunosorbent assay (ELISA)
815	CEES Exposure	Bronchoalveolar Lavage (BAL)	PLAT	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	3	3	Plasminogen Activator Activity Assay
816	CEES Exposure	Bronchoalveolar Lavage (BAL)	PLAT	DOWN	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rat	NM	Protein	6	6	Plasminogen Activator Activity Assay
968	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE1	NC	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rat	NM	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)
969	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE2	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rat	NM	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)
970	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE3	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rat	NM	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)
971	CEES Exposure	Liver	SERPINF2	UP	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rat	NM	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)
972	CEES Exposure	Kidney	SERPINF2	UP	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rat	NM	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)
973	CEES Exposure	Liver	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rat	NM	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)
974	CEES Exposure	Kidney	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rat	NM	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)
975	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rat	NM	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)

papers

Differential List